News for Savara Inc. (SVRA)

PR NewswireNEW YORK, June 1, 2025 NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. ("Sava

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. (”œSavara” or the ”œCompany”) (

U.S. stocks traded higher midway through trading, with the Dow Jones index jumping more than 600 points on Tuesday. President Donald Trump announced the extensi...

U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 300 points on Tuesday. President Donald Trump announced the extension of the...

Savara Inc. faces a setback with a refusal to file letter from the FDA. Molbreevi, intended for autoimmune pulmonary alveolar proteinosis, is at the cen

Savara (SVRA) stock in focus as FDA issues a refusal to file letter regarding its marketing application for its lead drug, Molbreevi. Read more here.

[url="]Savara Inc.[/url] (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of induceme

Savara Inc. (SVRA) has granted inducement awards to five new employees as part of their recruitment strategy. The equity awards consist of options for 8

[url="]Savara Inc.[/url] (Nasdaq: [url="]SVRA[/url]) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today anno

Savara Inc. (SVRA) grants inducement awards to seven new employees. Awards include stock options for 107,000 shares and RSUs for 83,000 shares. Stock

Savara boosts liquidity with a $200M loan from Hercules Capital, supporting MOLBREEVI's FDA review for autoimmune disease treatment.

Massachusetts-based Allurion Technologies Inc. (ALUR) is up over 64 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Massachusetts-based Allurion Technologies Inc. (ALUR) is up over 64 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Recession fears in the US are impacting Indian IT stocks, which have significantly slumped from their peaks. This and more in todays ETtech Top 5.

[url="]Savara Inc.[/url] (Nasdaq: [url="]SVRA[/url]) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today anno

On December 31, 2024, Vestal Point Capital, LP (Trades, Portfolio), a prominent investment firm, executed a noteworthy transaction by acquiring an additional 2,

[url="]Savara Inc.[/url] (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of induceme

SVRA Stock Touches 52-Week Low at $2.81 Amid Market Challenges